1,2-Dichloroethane → (E)-N-(3-ethyl-benzofuran-2-ylmethyl)-N-methyl-3-(2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylamide
반응식
[CH2:1]([C:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[O:5][C:4]=1[CH2:12][NH:13][CH3:14])[CH3:2].C(N(C(C)C)C(C)C)C.Cl.[O:25]=[C:26]1[NH:32][C:31]2[N:33]=[CH:34][C:35]([CH:37]=[CH:38][C:39]([OH:41])=O)=[CH:36][C:30]=2[CH2:29][NH:28][CH2:27]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl>CN(C=O)C.O>[CH2:1]([C:3]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[O:5][C:4]=1[CH2:12][N:13]([CH3:14])[C:39](=[O:41])/[CH:38]=[CH:37]/[C:35]1[CH:34]=[N:33][C:31]2[NH:32][C:26](=[O:25])[CH2:27][NH:28][CH2:29][C:30]=2[CH:36]=1)[CH3:2]참가 물질
8
반응물 5
생성물 1
시약·촉매·용매 2
실험 절차
A solution of (3-ethyl-benzofuran-2-ylmethyl)methylamine (185 mg, 0.979 mmol) and (i-Pr)2EtN (0.427 mL, 2.44 mmol) in DMF (25 mL) was treated successively with 3-(2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylic acid hydrochloride (250 mg, 0.816 mmol), HOBt (115 mg, 0.856 mmol), and EDC (316 mg, 2.44 mmol). After stirring overnight at room temperature, the mixture was diluted with water and then extracted with EtOAc (3×). The combined organics were washed with brine and dried, filtered and concentrated in vacuo. Purification by column chromatography (silica gel, CH2Cl2/CH3OH, 40:2 to 35:2) gave the title compound (125 mg, 37%) as a yellow solid: ESI MS m/z 405 (M+H)+.
후처리
- extractionextracted with EtOAc (3×)
- washThe combined organics were washed with brine
- customdried
- filtrationfiltered
- concentrationconcentrated in vacuo
- customPurification by column chromatography (silica gel, CH2Cl2/CH3OH, 40:2 to 35:2)
출처 및 근거
- ORD 기록
- ord-211320ae8ff247a1b8fbae586d5a31f0
- 출처 데이터셋
- uspto-grants-2013_05
- 특허 번호
- US08450307B2
반응 노트
불러오는 중…